283 related articles for article (PubMed ID: 9843152)
1. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
Coetzee T; Dupree JL; Popko B
J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
3. Galactolipids in the formation and function of the myelin sheath.
Dupree JL; Suzuki K; Popko B
Microsc Res Tech; 1998 Jun; 41(5):431-40. PubMed ID: 9672425
[TBL] [Abstract][Full Text] [Related]
4. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
5. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
[TBL] [Abstract][Full Text] [Related]
6. Effects of galactolipid elimination on oligodendrocyte development and myelination.
Marcus J; Dupree JL; Popko B
Glia; 2000 Jun; 30(4):319-28. PubMed ID: 10797612
[TBL] [Abstract][Full Text] [Related]
7. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.
Coetzee T; Fujita N; Dupree J; Shi R; Blight A; Suzuki K; Suzuki K; Popko B
Cell; 1996 Jul; 86(2):209-19. PubMed ID: 8706126
[TBL] [Abstract][Full Text] [Related]
8. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
9. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide.
Dupree JL; Coetzee T; Suzuki K; Popko B
J Neurocytol; 1998 Sep; 27(9):649-59. PubMed ID: 10447239
[TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of myelin galactolipid function.
Dupree JL; Popko B
J Neurocytol; 1999; 28(4-5):271-9. PubMed ID: 10739570
[TBL] [Abstract][Full Text] [Related]
11. Sulfatide is essential for the maintenance of CNS myelin and axon structure.
Marcus J; Honigbaum S; Shroff S; Honke K; Rosenbluth J; Dupree JL
Glia; 2006 Mar; 53(4):372-81. PubMed ID: 16288467
[TBL] [Abstract][Full Text] [Related]
12. Suppressed UDP-galactose: ceramide galactosyltransferase and myelin protein mRNA in twitcher mouse brain.
Taniike M; Marcus JR; Nishigaki T; Fujita N; Popko B; Suzuki K; Suzuki K
J Neurosci Res; 1998 Feb; 51(4):536-40. PubMed ID: 9514207
[TBL] [Abstract][Full Text] [Related]
13. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis.
Bosio A; Binczek E; Stoffel W
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13280-5. PubMed ID: 8917582
[TBL] [Abstract][Full Text] [Related]
14. Participation of galactosylceramide and sulfatide in glycosynapses between oligodendrocyte or myelin membranes.
Boggs JM; Gao W; Zhao J; Park HJ; Liu Y; Basu A
FEBS Lett; 2010 May; 584(9):1771-8. PubMed ID: 19941861
[TBL] [Abstract][Full Text] [Related]
15. Galactolipids are molecular determinants of myelin development and axo-glial organization.
Marcus J; Popko B
Biochim Biophys Acta; 2002 Dec; 1573(3):406-13. PubMed ID: 12417425
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of myelin galactolipid function.
Popko B; Dupree JL; Coetzee T; Suzuki K; Suzuki K
Adv Exp Med Biol; 1999; 468():237-44. PubMed ID: 10635033
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and functions of lipids in myelin.
Schmitt S; Castelvetri LC; Simons M
Biochim Biophys Acta; 2015 Aug; 1851(8):999-1005. PubMed ID: 25542507
[TBL] [Abstract][Full Text] [Related]
18. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice.
Bosio A; Binczek E; Haupt WF; Stoffel W
J Neurochem; 1998 Jan; 70(1):308-15. PubMed ID: 9422376
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
[TBL] [Abstract][Full Text] [Related]
20. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice.
Xin M; Yue T; Ma Z; Wu FF; Gow A; Lu QR
J Neurosci; 2005 Feb; 25(6):1354-65. PubMed ID: 15703389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
